Agenus
AGEN
#8421
Rank
A$0.43 B
Marketcap
A$9.59
Share price
3.06%
Change (1 day)
47.62%
Change (1 year)

Earnings for Agenus (AGEN)

Earnings in 2026 (TTM): A$0.22 Billion

According to Agenus 's latest financial reports the company's current earnings are A$0.13 Billion. In 2025 the company made an earning of A$78.23 Million, an increase over its 2024 earnings that were of -A$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agenus from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.22 B186%
2025 A$78.23 M-145.52%
2024 -A$0.18 Billion-28.13%
2023 -A$0.24 Billion-5.5%
2022 -A$0.26 Billion-556.26%
2021 A$55.45 M-130.37%
2020 -A$0.19 Billion73.75%
2019 -A$0.11 Billion-48.74%
2018 -A$0.21 Billion34.32%
2017 -A$0.16 Billion-7.16%
2016 -A$0.17 Billion26.55%
2015 -A$0.13 Billion110.24%
2014 -A$61.8 Million49.12%
2013 -A$41.44 Million
2011 -A$28.62 Million-12.25%
2010 -A$32.61 Million-21.41%
2009 -A$41.5 Million-26.86%
2008 -A$56.73 Million13.72%
2007 -A$49.89 Million-33.4%
2006 -A$74.91 Million-31.84%
2005 -A$0.11 Billion9.74%
2004 -A$0.11 Billion-0.8%
2003 -A$0.11 Billion17.37%
2002 -A$86.01 Million37.83%
2001 -A$62.4 Million55.99%
2000 -A$40.01 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$28.06 B 12,294.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$10.07 B 4,351.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$16.98 B 7,402.75%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$10.72 B 4,636.87%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-A$0.49 Billion-315.73%๐Ÿ‡บ๐Ÿ‡ธ USA